[EN] PROCESSES FOR PREPARING INDOLES<br/>[FR] PROCÉDÉS DE PRÉPARATION D'INDOLES
申请人:UNIV NANYANG TECH
公开号:WO2013095304A1
公开(公告)日:2013-06-27
Methods for the synthesis of an indole in provided. Methods comprise oxidizing a N-aryl imine in the presence of a palladium-based catalyst, an oxidant, and a solvent.
Methods for the synthesis of an indole in provided. Methods comprise oxidizing a N-aryl imine in the presence of a palladium-based catalyst, an oxidant, and a solvent.
Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II
申请人:LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES
公开号:US10179816B2
公开(公告)日:2019-01-15
The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.
本发明涉及新型药物组合物,其活性成分包括结合人抗苗勒氏激素 II 型受体(AMHR-II)的抗体和抗癌剂,以及这些组合物的治疗应用。
NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIBODY WHICH BINDS THE HUMAN ANTI-MULLERIAN HORMONE RECEPTOR TYPE II
申请人:Gaucher Christine
公开号:US20150004156A1
公开(公告)日:2015-01-01
The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.
NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIBODY WHICH BINDS THE HUMAN ANTI-MÜLLERIAN HORMONE RECEPTOR TYPE II
申请人:LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES
公开号:US20170101478A1
公开(公告)日:2017-04-13
The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.